InvestorsHub Logo
Followers 166
Posts 36223
Boards Moderated 6
Alias Born 10/20/2019

Re: Robertscott post# 2643

Tuesday, 02/28/2023 9:38:15 AM

Tuesday, February 28, 2023 9:38:15 AM

Post# of 2792
Absolutely and more updates forthcoming...

Nascent will continue to collect and evaluate the Clinical data from the Phase I trial as it prepares to submit results to the U.S. FDA for Phase II consideration.

$NBIO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBIO News